AAAAAA

   
Results: 1-8 |
Results: 8
WHEN ARE 2ND ALLOGENEIC BONE-MARROW TRANSPLANTS INDICATED IN PEDIATRIC-PATIENTS
Authors: CALDERWOOD S DOYLE JJ ROLLANDGRINTON M ZAFAR M ROIFMAN C FREEDMAN MH SAUNDERS EF
Citation: S. Calderwood et al., WHEN ARE 2ND ALLOGENEIC BONE-MARROW TRANSPLANTS INDICATED IN PEDIATRIC-PATIENTS, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 337-343
TREATMENT OF HYPEREOSINOPHILIC SYNDROME IN A CHILD USING CYCLOSPORINE- IMPLICATION FOR A PRIMARY T-CELL ABNORMALITY
Authors: NADARAJAH S KRAFCHIK B ROIFMAN C HORGANBELL C
Citation: S. Nadarajah et al., TREATMENT OF HYPEREOSINOPHILIC SYNDROME IN A CHILD USING CYCLOSPORINE- IMPLICATION FOR A PRIMARY T-CELL ABNORMALITY, Pediatrics, 99(4), 1997, pp. 630-633
HUMAN CD4(-CORD BLOOD T-CELLS COLONIZE MURINE FETAL THYMUS LOBES IN-VITRO AND REGULATE THE DEVELOPMENT OF HUMAN T-LYMPHOCYTES IN A CYTOKINE-DEPENDENT MANNER() AND CD8(+) UMBILICAL)
Authors: LAPIDOT T KOLLET O ABEL L BALLIN A NAGLER A SLAVIN S SHARP A WILLIAMS D LYMAN S ROIFMAN C GLOBERSON A
Citation: T. Lapidot et al., HUMAN CD4(-CORD BLOOD T-CELLS COLONIZE MURINE FETAL THYMUS LOBES IN-VITRO AND REGULATE THE DEVELOPMENT OF HUMAN T-LYMPHOCYTES IN A CYTOKINE-DEPENDENT MANNER() AND CD8(+) UMBILICAL), Blood, 88(10), 1996, pp. 2894-2894
3 NEW ADENOSINE-DEAMINASE MUTATIONS THAT DEFINE A SPLICING ENHANCER AND CAUSE SEVERE AND PARTIAL PHENOTYPES - IMPLICATIONS FOR EVOLUTION OFA CPG HOTSPOT AND EXPRESSION OF A TRANSDUCED ADA CDNA
Authors: SANTISTEBAN I ARREDONDOVEGA FX KELLY S LOUBSER M MEYDAN N ROIFMAN C HOWELL PL BOWEN T WEINBERG KI SCHROEDER ML HERSHFIELD MS
Citation: I. Santisteban et al., 3 NEW ADENOSINE-DEAMINASE MUTATIONS THAT DEFINE A SPLICING ENHANCER AND CAUSE SEVERE AND PARTIAL PHENOTYPES - IMPLICATIONS FOR EVOLUTION OFA CPG HOTSPOT AND EXPRESSION OF A TRANSDUCED ADA CDNA, Human molecular genetics, 4(11), 1995, pp. 2081-2087
LOCALIZED PULMONARY RESECTION FOR BRONCHIECTASIS IN HYPOGAMMAGLOBULINEMIC PATIENTS
Authors: COHEN AJ ROIFMAN C MULLEN JBM REID B WEISBROD G DOWNEY GP
Citation: Aj. Cohen et al., LOCALIZED PULMONARY RESECTION FOR BRONCHIECTASIS IN HYPOGAMMAGLOBULINEMIC PATIENTS, Thorax, 49(5), 1994, pp. 509-510
DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
Authors: BERKOVITCH M MEYDAN N DONSKY J COLLINS AF SHER GD MATSUI D KOREN G HACKMAN R ROIFMAN C OLIVIERI NF
Citation: M. Berkovitch et al., DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY, Pediatric research, 35(4), 1994, pp. 10000158-10000158
ENVELOPE GLYCOPROTEINS OF HIV-1 INTERFERE WITH T-CELL-DEPENDENT B-CELL DIFFERENTIATION - ROLE OF CD4 MHC CLASS-II INTERACTION IN THE EFFECTOR PHASE OF T-CELL HELP
Authors: CHIRMULE N WANG XP HU R OYAIZU N ROIFMAN C PAHWA R KALYANARAMAN VS PAHWA S
Citation: N. Chirmule et al., ENVELOPE GLYCOPROTEINS OF HIV-1 INTERFERE WITH T-CELL-DEPENDENT B-CELL DIFFERENTIATION - ROLE OF CD4 MHC CLASS-II INTERACTION IN THE EFFECTOR PHASE OF T-CELL HELP, Cellular immunology, 155(1), 1994, pp. 169-182
DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
Authors: BERKOVITCH M MEYDAN N DONSKY J COLLINS AF SHER GD MATSUI D KOREN G HACKMAN R ROIFMAN C OLIVIERI NF
Citation: M. Berkovitch et al., DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVINGTHE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY, Blood, 82(10), 1993, pp. 10000360-10000360
Risultati: 1-8 |